+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Custom Antibody Market by Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), Service (Antibody Development, Antibody Fragmentation & Labeling, Antibody Production & Purification), Source, Research Area, End Users, Application - Forecast 2024-2030- Product Image
Global Custom Antibody Market by Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), Service (Antibody Development, Antibody Fragmentation & Labeling, Antibody Production & Purification), Source, Research Area, End Users, Application - Forecast 2024-2030- Product Image
Sale

Global Custom Antibody Market by Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), Service (Antibody Development, Antibody Fragmentation & Labeling, Antibody Production & Purification), Source, Research Area, End Users, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674843
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Custom Antibody Market size was estimated at USD 755.86 million in 2023, USD 871.88 million in 2024, and is expected to grow at a CAGR of 16.10% to reach USD 2,149.90 million by 2030.

Custom antibodies are specialized proteins designed and produced to bind specifically to a single target molecule, known as an antigen. These antibodies are tailor-made to recognize and bind with high specificity to unique sites on target molecules, making them valuable tools in research, diagnostic, and therapeutic applications. The custom production of antibodies allows researchers to generate specific reagents for novel or less-studied targets or to create antibodies with desired properties that are not available off the shelf. The high prevalence and incidences of chronic and infectious diseases worldwide necessitate the development of novel diagnostic and therapeutic antibodies.

Heightened investment in research and development by biopharmaceutical companies and academic institutions boosts the proliferation of custom antibodies. However, the intricate processes involved in custom antibody production can be cost-intensive, and stringent regulatory requirements for antibody therapeutics can delay market entry and increase development costs. Moreover, generating antibodies with high specificity and affinity remains challenging, impacting the effectiveness of custom antibody applications. However, key players are exploring the integration of AI/ML algorithms and robotics technologies to ease the process of antibody discovery and design. Furthermore, the development of more efficient hybridoma technology and recombinant antibody production and expanding applications in targeted drug delivery systems and diagnostic imaging could also benefit the growth of the industry.

Regional Insights

The Americas, particularly the U.S. and Canada, are known for their robust research environments, contributing significantly to the demand for custom antibodies. The region's strong biotechnology and pharmaceutical sectors drive this need, with both academic and commercial labs seeking high-quality, specific antibodies for therapeutic and diagnostic applications. Recent patents in the U.S. indicate a focus on novel cancer biomarkers and neurodegenerative diseases, highlighting the ongoing innovation in antibody development. European Union (EU) countries boast advanced healthcare systems and strong regulatory support for biotechnology research, fostering a conducive environment for custom antibody development.

The presence of stringent regulations for therapeutics and diagnostics molecules in the EU provides a standardized and secure framework for the progression of custom antibodies. Recent EU investments focus on combating infectious diseases and addressing chronic conditions, such as autoimmune disorders, through innovative antibody solutions. The APAC region has emerged as a pivotal landscape in the custom antibody market, supported by several government-funded initiatives to advance the healthcare infrastructure and provide marginalized communities access to diagnostics and therapeutic capabilities. China's focus on biotechnology innovation and government investments in genomics and proteomics research is creating a need for highly specialized antibodies. Japan's well-established pharmaceutical industry prioritizes precision medicine, and India's burgeoning biotechnology sector, coupled with its cost-effective manufacturing capabilities, has proved crucial for the growth of custom antibodies.

Market Trends by Segment

  • Type: Emerging need for monoclonal antibodies to tackle severe disease states
  • End Users: Expanding investments by the pharmaceutical & biotechnology companies in drug development and diagnostics

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Danaher to Buy Antibody Supplier Abcam for USD 5.7 Billion

Danaher Corporation has announced its plan to acquire Abcam, a key of antibodies, reagents, biomarkers, and assays based in Cambridge, England, for an estimated USD 5.7 billion in cash. This move aims to consolidate their positions within the life sciences tools and consumables sector to strengthen market presence.

Merck to Develop mAb Through USD 10.8 Billion Acquisition

Merck & Co. Inc has announced a strategic move to enhance its immunology portfolio through the acquisition of Prometheus Biosciences for USD 10.8 billion. This significant transaction paves the way for Merck to further the development of PRA023, a cutting-edge humanized monoclonal antibody (mAb) aimed at treating ulcerative colitis (UC), Crohn's disease (CD), and other autoimmune ailments. The collaboration is expected to leverage Prometheus's expertise in clinical-stage biotechnological research, driving forward the precision treatment of immune diseases.

Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies

Celltrion and Genuv have announced their joint venture into the custom antibody market, bringing together decades of collective experience and expertise. Their combined mission is to provide customers with highly tailored antibodies so they can continue to develop innovative treatments and drugs quickly and accurately, creating greater access for those who desperately seek improved healthcare solutions. By leveraging Celltrion's extensive R&D capabilities and Genuv's cutting-edge technology platforms, this partnership is perfectly poised to enter the global market and ultimately deliver more effective and affordable antibody therapies that will benefit both drug manufacturers and patients alike.

Key Company Profiles

The report delves into recent significant developments in the Custom Antibody Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, ABclonal, Inc., Abgenex Pvt. Ltd., Abnova Corporation, Acrobiosystems Inc., Agilent Technologies, Inc., Alta Bioscience Limited, Bio Basic Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioChain Incorporated, Bioklone Biotech Private Limited, BioLegend, Inc. by PerkinElmer, Inc., Biosynth Ltd., Boster Biological Technology, BTL Biotechno Labs Private Limited, Capralogics, Inc., Cell Signaling Technology, Inc., CiteAb Limited, Creative Biolabs, Creative Diagnostics, CSBio (Shanghai) Ltd., Cusabio Technology LLC, Davids Biotechnologie GmbH, Elabscience, evitria AG by Atlas Antibiodies, GenScript Biotech Corporation, Imgenex India Pvt. Ltd., Innovagen AB, Inotiv, Inc., Kaneka Eurogentec S.A., Laboratory Corporation of America Holdings, Merck KGaA, Metabion International AG, MyBiosource, Inc., OriGene Technologies, Inc., Oy Medix Biochemica AB, Pacific Immunology, PhosphoSolutions, ProMab Biotechnologies, Inc., ProSci Incorporated, ProteoGenix SA, RayBiotech Life, Inc., Rockland Immunochemicals, Inc., Sino Biological, Inc., The Antibody Company, Thermo Fisher Scientific, Inc., and YenZym Antibodies, LLC.

This research report offers invaluable insights into various crucial aspects of the Custom Antibody Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic infectious disease worldwide
5.1.1.2. Expanding applications of custom antibody across research, diagnostics, and therapeutics
5.1.1.3. Rising adoption of advanced technologies in antibody engineering and personalized therapeutics
5.1.2. Restraints
5.1.2.1. Extensive and time consuming to develop custom antibodies
5.1.3. Opportunities
5.1.3.1. Governments and private sector strategically investments in life science and clinical research
5.1.3.2. Increase in therapeutics of antibodies and expansion of drug pipeline
5.1.4. Challenges
5.1.4.1. Presence of alternative antibodies
5.2. Market Segmentation Analysis
5.2.1. Type: Emerging need for monoclonal antibodies to tackle severe disease states
5.2.2. End Users: Expanding investments by the pharmaceutical & biotechnology companies in drug development and diagnostics
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Custom Antibody Market, by Type
6.1. Introduction
6.2. Monoclonal Antibodies
6.3. Polyclonal Antibodies
6.4. Recombinant Antibodies
7. Custom Antibody Market, by Service
7.1. Introduction
7.2. Antibody Development
7.3. Antibody Fragmentation & Labeling
7.4. Antibody Production & Purification
8. Custom Antibody Market, by Source
8.1. Introduction
8.2. Mice
8.3. Rabbit
9. Custom Antibody Market, by Research Area
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Immunology
9.4. Infectious Diseases
9.5. Neurobiology
9.6. Oncology
9.7. Stem cells
10. Custom Antibody Market, by End Users
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotechnology Companies
11. Custom Antibody Market, by Application
11.1. Introduction
11.2. Research
11.3. Therapeutics
12. Americas Custom Antibody Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Custom Antibody Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Custom Antibody Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Danaher to Buy Antibody Supplier Abcam for USD 5.7 Billion
15.3.2. Merck to Develop mAb Through USD 10.8 Billion Acquisition
15.3.3. Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies
15.4. Strategy Analysis & Recommendation
16. Competitive Portfolio
16.1. Key Company Profiles
16.2. Key Product Portfolio
List of Figures
FIGURE 1. CUSTOM ANTIBODY MARKET RESEARCH PROCESS
FIGURE 2. CUSTOM ANTIBODY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CUSTOM ANTIBODY MARKET DYNAMICS
FIGURE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 18. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 28. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CUSTOM ANTIBODY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 100. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 101. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 102. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 103. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 104. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 105. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 106. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 107. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 112. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 113. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 114. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 115. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 116. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 117. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 118. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 119. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 134. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 142. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 144. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 148. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 153. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 154. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 155. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 156. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 157. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 158. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 159. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 164. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 165. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 166. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 167. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 168. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 169. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 170. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 171. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 174. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 175. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 176. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 177. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 178. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 179. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 180. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 181. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 182. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 183. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 189. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 190. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 191. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 192. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 193. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 194. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 195. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 198. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 199. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 200. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 201. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 202. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 203. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 204. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 205. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 206. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 207. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 213. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 214. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 215. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 216. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 217. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 218. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 219. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 225. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 226. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 227. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 228. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 229. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 230. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 231. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 237. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 238. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 239. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 240. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 241. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 242. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 243. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 249. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 251. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 252. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 253. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 254. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 255. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 261. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 262. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 263. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 264. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 265. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 266. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 267. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 270. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 271. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 272. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 273. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 274. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 275. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 276. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 277. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 278. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 279. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 282. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 283. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 284. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 285. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 286. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 287. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 288. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 289. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 290. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 291. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 307. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 308. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 309. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 310. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 311. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 312. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 313. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 314. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 315. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 316. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 317. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 320. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 321. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 322. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 323. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 324. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 325. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 326. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 327. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 328. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 329. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 332. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 333. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 334. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 335. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 336. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 337. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 338. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 339. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 340. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 341. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 344. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 345. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 346. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 347. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 348. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 349. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 350. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 351. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 352. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 353. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 354. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 355. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 356. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 357. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 358. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 359. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 360. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 361. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
TABLE 362. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
TABLE 363. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 364. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 365. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 366. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 367. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 368. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 369. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
TABLE 370. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
TABLE 371. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLI

Companies Mentioned

  • Abbiotec, Inc.
  • Abcam PLC
  • ABclonal, Inc.
  • Abgenex Pvt. Ltd.
  • Abnova Corporation
  • Acrobiosystems Inc.
  • Agilent Technologies, Inc.
  • Alta Bioscience Limited
  • Bio Basic Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioChain Incorporated
  • Bioklone Biotech Private Limited
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Biosynth Ltd.
  • Boster Biological Technology
  • BTL Biotechno Labs Private Limited
  • Capralogics, Inc.
  • Cell Signaling Technology, Inc.
  • CiteAb Limited
  • Creative Biolabs
  • Creative Diagnostics
  • CSBio (Shanghai) Ltd.
  • Cusabio Technology LLC
  • Davids Biotechnologie GmbH
  • Elabscience
  • evitria AG by Atlas Antibiodies
  • GenScript Biotech Corporation
  • Imgenex India Pvt. Ltd.
  • Innovagen AB
  • Inotiv, Inc.
  • Kaneka Eurogentec S.A.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Metabion International AG
  • MyBiosource, Inc.
  • OriGene Technologies, Inc.
  • Oy Medix Biochemica AB
  • Pacific Immunology
  • PhosphoSolutions
  • ProMab Biotechnologies, Inc.
  • ProSci Incorporated
  • ProteoGenix SA
  • RayBiotech Life, Inc.
  • Rockland Immunochemicals, Inc.
  • Sino Biological, Inc.
  • The Antibody Company
  • Thermo Fisher Scientific, Inc.
  • YenZym Antibodies, LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 871.88 Million
Forecasted Market Value ( USD ) by 2030 $ 2149.9 Million
Compound Annual Growth Rate16.1%
Regions CoveredGlobal
No. of Companies Mentioned49

Related Topics

Related Reports

Custom Antibody - Global Strategic Business Report - Product Image

Custom Antibody - Global Strategic Business Report

  • Report
  • 127 Pages
  • Global
From
Global Custom Antibody Market Report and Forecast 2024-2032 - Product Image

Global Custom Antibody Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
2024 Global Forecast for Custom Antibody Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Custom Antibody Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Global Biopharmaceuticals Market by Product Type, Services, Raw Material Type, Application - Forecast 2024-2030 - Product Image

Global Biopharmaceuticals Market by Product Type, Services, Raw Material Type, Application - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Non-Therapeutic Biomolecules Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Non-Therapeutic Biomolecules Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 182 Pages
  • Global
From

About the Custom Antibody Market

The Custom Antibody market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic proteins and antibodies. Custom Antibodies are antibodies that are designed and produced to specifically target a particular antigen. They are used in a variety of applications, such as diagnostics, drug discovery, and therapeutic treatments. Custom Antibodies are produced through a variety of methods, including hybridoma technology, phage display, and recombinant DNA technology. Custom Antibodies are used in a variety of research and clinical applications, including immunoassays, immunohistochemistry, flow cytometry, and ELISA. They are also used in drug discovery and development, as well as in the development of therapeutic treatments. Some companies in the Custom Antibody market include Abcam, Bio-Rad, Merck Millipore, Thermo Fisher Scientific, and GenScript. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.